We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.5%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21.1B
AUM Growth
-$321M
(-1.5%)
Cap. Flow
-$667M
Cap. Flow
% of AUM
-3.16%
Top 10 Holdings %
Top 10 Hldgs %
44.4%
Holding
278
New
11
Increased
22
Reduced
116
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinder Morgan
KMI
|
+$378M |
| 2 |
CELG
Celgene Corp
CELG
|
+$82M |
| 3 |
State Street
STT
|
+$42.4M |
| 4 |
American Express
AXP
|
+$28.8M |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$20.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$423M |
| 2 |
Coca-Cola
KO
|
+$73.5M |
| 3 |
Freeport-McMoran
FCX
|
+$69.9M |
| 4 |
HSBC
HSBC
|
+$65.3M |
| 5 |
Johnson & Johnson
JNJ
|
+$55.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 28.8% |
| 2 | Energy | 23.3% |
| 3 | Financials | 13.25% |
| 4 | Healthcare | 11.44% |
| 5 | Technology | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Philip Morris
PM
$313B
| $1.5B | 7.1% |
18,398,412
-429,956
| -2% | -$36.9M |
|
2
ExxonMobil
XOM
$653B
| $1.34B | 6.33% |
14,440,876
-374,453
| -3% | -$34.9M |
|
|
3
Coca-Cola
KO
$388B
| $1.24B | 5.87% |
29,351,387
-1,720,730
| -6% | -$73.5M |
|
4
Altria Group
MO
$126B
| $936M | 4.44% |
19,002,054
-453,128
| -2% | -$22.1M |
|
5
Apple
AAPL
$5.01T
| $803M | 3.81% |
29,140,644
-1,997,564
| -6% | -$54.3M |
|
6
Chevron
CVX
$383B
| $786M | 3.73% |
7,003,868
-173,003
| -2% | -$19.7M |
|
|
7
Kinder Morgan
KMI
$70.9B
| $783M | 3.71% |
18,497,223
+9,602,595
| +108% | +$378M |
|
8
Procter & Gamble
PG
$337B
| $694M | 3.29% |
7,624,674
-246,531
| -3% | -$21.7M |
|
9
T. Rowe Price
TROW
$25.7B
| $688M | 3.26% |
8,013,935
| – | – |
|
10
Enterprise Products Partners
EPD
$84B
| $602M | 2.86% |
16,675,394
+67,238
| +0.4% | +$2.49M |
|
|
11
Johnson & Johnson
JNJ
$646B
| $528M | 2.5% |
5,044,909
-524,495
| -9% | -$55.3M |
|
12
JPMorgan Chase
JPM
$926B
| $376M | 1.78% |
6,005,822
-207,284
| -3% | -$12.5M |
|
13
PepsiCo
PEP
$198B
| $345M | 1.64% |
3,648,164
-111,001
| -3% | -$10.6M |
|
14
McDonald's
MCD
$194B
| $337M | 1.6% |
3,600,635
-574,129
| -14% | -$53.7M |
|
15
AbbVie
ABBV
$471B
| $330M | 1.56% |
5,031,458
-178,407
| -3% | -$11.2M |
|
16
ConocoPhillips
COP
$144B
| $314M | 1.49% |
4,543,838
-144,907
| -3% | -$10.1M |
|
|
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
| $307M | 1.46% |
4,030,202
-221,816
| -5% | -$14.8M |
|
|
BNY
18
Bank of New York Mellon
BNY
$105B
| $300M | 1.42% |
7,396,249
-350
| -0% | -$13.7K |
|
|
NVO
19
Novo Nordisk
NVO
$227B
| $282M | 1.34% |
13,312,742
-201,426
| -1% | -$4.5M |
|
20
Mondelez International
MDLZ
$83.9B
| $280M | 1.33% |
7,701,126
-999,466
| -11% | -$36.4M |
|
21
Walmart Inc
WMT
$906B
| $278M | 1.32% |
9,720,057
-458,742
| -5% | -$12.4M |
|
22
Abbott
ABT
$191B
| $276M | 1.31% |
6,135,226
-132,214
| -2% | -$5.76M |
|
23
IBM
IBM
$214B
| $257M | 1.22% |
1,673,781
-92,539
| -5% | -$14.7M |
|
24
Texas Instruments
TXN
$246B
| $255M | 1.21% |
4,771,224
+91,702
| +2% | +$4.64M |
|
25
Merck
MRK
$325B
| $253M | 1.2% |
4,658,883
-420,642
| -8% | -$23.4M |
|
Similar funds
HF
Fayez Sarofim & Co's Q4 2014 Portfolio in Review
As of Q4 2014, Fayez Sarofim & Co held 278 positions worth $21.1B, down 1.5% from $21.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Fayez Sarofim & Co withdrew a net $667M in Q4 2014, closing 28 positions and reducing 116 holdings. Its most notable exit was KINDER MORGAN ENER PNTRS L.P., an estimated $423M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, up from 29% a quarter earlier, followed by Energy and Financials.
Against the trend, Fayez Sarofim & Co opened a new position in Celgene Corp worth $87.3M.
- Fayez Sarofim & Co's largest Q4 2014 buy was Celgene Corp: 777,494 shares worth $87.3M.
- Fayez Sarofim & Co added most to Kinder Morgan in Q4 2014, an estimated $378M increase.
- Fayez Sarofim & Co's biggest Q4 2014 reduction was Coca-Cola, cutting an estimated $73.5M.
- Fayez Sarofim & Co fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $423M.
- Fayez Sarofim & Co's ten largest holdings make up 44% of its $21.1B portfolio in Q4 2014.
- Fayez Sarofim & Co opened 11 new positions and closed 28 in Q4 2014.
- Fayez Sarofim & Co's portfolio value fell 1.5% quarter-over-quarter to $21.1B.
Based on Fayez Sarofim & Co's 13F filing for Q4 2014, filed 13 Feb 2015.